1. Home
  2. RAIL vs INBX Comparison

RAIL vs INBX Comparison

Compare RAIL & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAIL
  • INBX
  • Stock Information
  • Founded
  • RAIL 1901
  • INBX 2010
  • Country
  • RAIL United States
  • INBX United States
  • Employees
  • RAIL N/A
  • INBX N/A
  • Industry
  • RAIL Railroads
  • INBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAIL Industrials
  • INBX Health Care
  • Exchange
  • RAIL Nasdaq
  • INBX Nasdaq
  • Market Cap
  • RAIL 155.7M
  • INBX 178.5M
  • IPO Year
  • RAIL N/A
  • INBX 2020
  • Fundamental
  • Price
  • RAIL $8.74
  • INBX $14.98
  • Analyst Decision
  • RAIL
  • INBX Hold
  • Analyst Count
  • RAIL 0
  • INBX 1
  • Target Price
  • RAIL N/A
  • INBX N/A
  • AVG Volume (30 Days)
  • RAIL 136.4K
  • INBX 82.4K
  • Earning Date
  • RAIL 08-11-2025
  • INBX 08-12-2025
  • Dividend Yield
  • RAIL N/A
  • INBX N/A
  • EPS Growth
  • RAIL N/A
  • INBX N/A
  • EPS
  • RAIL N/A
  • INBX 111.58
  • Revenue
  • RAIL $494,657,000.00
  • INBX $200,000.00
  • Revenue This Year
  • RAIL $3.13
  • INBX N/A
  • Revenue Next Year
  • RAIL $5.86
  • INBX N/A
  • P/E Ratio
  • RAIL N/A
  • INBX $0.13
  • Revenue Growth
  • RAIL 12.90
  • INBX N/A
  • 52 Week Low
  • RAIL $3.02
  • INBX $10.80
  • 52 Week High
  • RAIL $16.10
  • INBX $17.79
  • Technical
  • Relative Strength Index (RSI)
  • RAIL 58.53
  • INBX 59.12
  • Support Level
  • RAIL $8.52
  • INBX $13.97
  • Resistance Level
  • RAIL $8.97
  • INBX $15.18
  • Average True Range (ATR)
  • RAIL 0.37
  • INBX 0.72
  • MACD
  • RAIL -0.06
  • INBX -0.07
  • Stochastic Oscillator
  • RAIL 57.14
  • INBX 55.21

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: